Resonance Health China Roadshow - March 2026

Resonance Health explores China market opportunities — five days - four cities. 

We are excited to share highlights from our Hong Kong & China Roadshow during March, where our team — Andrew Harrison (MD & CEO), Dr Wenjie Pang (CSO) and Ben Carruthers (CFO)— explored commercial opportunities for our non-invasive MRI imaging products across the region. 

Our LiverSmart® AI-powered multi-parametric MRI solution — which measures liver iron and liver fat in a single scan — generated strong interest at every stop, particularly within China's rapidly expanding medical tourism and high-end health check sectors. 

Shulan (Boao) Hospital — Hainan 

Oasis International Hospital, Beijing 

 Dr Wenjie Pang & Ben Carruthers at Oasis, Beijing 

Key highlights from the trip: 

🏛️ Boao Lecheng International Medical Tourism Pilot Zone — Administration 

Deputy Director Ms Fu Zhu confirmed that LiverSmart® "meets conditions for introduction" under Lecheng's licensed product policy — which grants access to innovative devices approved in other countries before Chinese NMPA registration, with priority real-world data pathways to full approval. 

🏥 Shulan (Boao) Hospital  

One of Lecheng's largest specialist hospitals. Their team confirmed strong alignment with LiverSmart® — and agreed in principle to the product "landing in the hospital", with detailed technical and pricing discussions underway. Shulan medical group has over 7,000 private hospital beds across China. 

🌿 Boao Yiling Life Care Centre 

A premium international medical tourism destination with 500,000 members across 6 major campuses. Their team confirmed LiverSmart® aligns with their non-invasive testing philosophy and could be included in their VIP Health Check Package. 

🔬 International Innovative Pharmaceuticals & Devices Product Promotion Conference 

Dr Pang was invited to present at the Lecheng Administration's official Product Promotion Conference — attended by Hainan government health leaders.